Page 97 - Annual Report
P. 97

HONG KONG ACADEMY OF MEDICINE
                       學
                     醫
                   港
                         專
                               院
                             學
                           科
                 香 香港醫學專科學院
                 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
                 FOR THE YEAR ENDED 31 DECEMBER 2022




                 19.  FINANCIAL INSTRUMENTS (Continued)

                      b)   Liquidity risk (Continued)

                                                                 Contractual undiscounted
                                                                       cash outflow
                                                                                    Total       Carrying
                                                                   Within     contractual        amount
                                                                 1 year or   undiscounted          at 31
                                                               on demand        cash flow     December
                                                                     HK$            HK$             HK$

                          For the year ended 31 December
                            2022

                          Non-derivative financial liabilities
                            Accruals and other payables         7,506,425      7,506,425       7,506,425

                          For the year ended 31 December
                            2021

                          Non-derivative financial liabilities
                            Accruals and other payables         5,921,355      5,921,355       5,921,355

                      c)   Interest rate risk

                          The Group is exposed to interest rate risk only to the extent that it earns bank interest on
                          cash and deposits.

                          The effective interest rates per annum relating to cash at bank and time deposits at the
                          end of the reporting period ranges from 0.01% to 4.85% (2021: 0.01% to 0.68%) for the
                          Group.

                          Sensitivity analysis

                          At  31  December  2022,  it is estimated that  a  general increase/decrease of 100 basis
                          points in interest rates, with all other variables held constant, would decrease/increase
                          the  Group’s  deficit  for  the  year  and  increase/decrease  the  Group’s  general  fund  by
                          approximately HK$686,000 (2021: HK$774,000). Other components of equity would not
                          be affected (2021: HK$Nil) by the changes in interest rates.

                          The  sensitivity  analysis  above  has  been  determined  assuming  that  the  change  in
                          interest rates had occurred at the end of the reporting period and had been applied to
                          the exposure to interest rate risk for financial instruments in existence at that date. The
                          100  basis  point  increase  represents  management’s  assessment  of  a  reasonably
                          possible change in interest rates over the period until the end of next reporting period.
                          The analysis is performed on the same basis for 2021.








                                                           30



                                                                                         香港醫學專科學院 2023 年度報告     95
   92   93   94   95   96   97   98   99   100   101   102